Project overview
Idiopathic pulmonary fibrosis (IPF) is a life-threatening condition of the lungs where tissue becomes thickened, stiff, and scarred, limiting the amount of oxygen getting into the blood. The aim of this project is to provide effective targeted therapies for sufferers to reduce symptoms of this devastating disease and improve their quality of life as well as to identify biomarkers for IPF patients.
Staff
Lead researchers
Collaborating research institutes, centres and groups
Research outputs
Xiaofan Liu, Hong Zhou, Yilu Zhou, Xiaojun Wu, Yang Zhao, Yang Lu, Weijun Tan, Mingli Yuan, Xuhong Ding, Jinjing Zou, Ruiyun Li, Hailing Liu, Robert Ewing, Yi Hu, Hanxiang Nie & Yihua Wang,
2020, Journal of Infection, 81(1), e95-e97
Type: letterEditorial
Franco Conforti, Robert Ridley, Christopher J Brereton, Aiman Alzetani, Mark Jones, Donna Davies, Paul Skipp, Yihua Wang, Christian Ottensmeier, B. Marshall, Sophie Fletcher, Luca Richeldi & Benjamin Johnson,
2020, Cell Death and Discovery, 6
Type: article
Dian Liu, Ayse Ertay, Charlotte Hill, Yilu Zhou, Juanjuan Li, Yanmei Zou, Hong Qiu, Xianglin Yuan, Robert Ewing, Xin Lu, Hua Xiong & Yihua Wang,
2020, Cell Death and Disease, 11(4)
Type: article
Yuan Yuan, Yilu Zhou, Yali Li, Charlotte Hill, Robert Ewing, Mark Jones, Donna Davies, Zhenglin Jiang & Yihua Wang,
2020, International Journal of Molecular Sciences, 21(4), 1-19
DOI: 10.3390/ijms21041371
Type: article